References
- Schuknecht HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1957; 132: 1–41.
- Lange G. Gentamicin and other ototoxic antibiotics for the transtympanic treatment of Meniere's disease. Arch Otorhinolaryngol 1989; 246: 269–70.
- Hirsch BE, Kamerer DB. Role of chemical labyrinthect-omy in the treatment of Meniere's disease. Otolaryngol Clin North Am 1997; 30: 1039–49.
- Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000; 110: 236–40.
- Bagger-Sj�b�ck D, Bergenius J, Lundberg AM. Inner ear effects of topical gentamicin treatment in patients with Meniere's disease. Am J Otol 1990; 11: 406–10.
- Wanamaker HH, Gruenwald L, Damm KJ, Ogata Y, Slepecky N. Dose-related vestibular and cochlear effects of transtympanic gentamicin. Am J Otol 1998; 19: 170� 9.
- Nakashima T, Teranishi M, Hibi T, Kobayashi M, Umemura M. Vestibular and cochlear toxicity of aminoglycosides- a review. Acta Otolaryngol 2000; 120:904–11.
- Kohlhepp S J, Loveless MO, Kohnen PW, Houghton DC, Bennett WM, Gilbert DN. Nephrotoxicity of the constituents of gentamicin complex. J Infect Dis 1984; 149: 605–14.
- Isoherranen N, Lavy E, Soback S. Pharmacokinetics of gentamicin CI, Cla and C2 in beagles after a single intravenous dose. Antimicrob Agents Chemother 2000; 44: 1443–7.
- Forrey AW, Meijsen-Ludwick BT, O'Neill MA, Maxwell BM, Blair AD, Cutler RE. Nephrotoxicity: a compar�ison in humans of gentamicin and gentamicin CI administration. Toxicol Appi Pharmacol 1978; 44: 453–62.
- Fox KE, Brummett RE, Brown R, Himes D. A comparative study of the ototoxicity of gentamicin and gentamicin CI. Arch Otolaryngol 1980; 106: 44–9.
- Bock GR, Yates GK, Miller JJ, Moorjani P. Effects of N-acetylcysteine on kanamycin ototoxity in the guinea pig. Hear Res 1996; 743: 337–40.
- Song BB, Schacht J. Variable efficacy of radical scaven�gers and iron chelators to attenuate gentamicin ototoxi�city in guinea pig in vivo. Hear Res 1996; 94: 87–93.
- Takumida M, Popa R, Anniko M. Free radicals in the guinea pig inner ear following gentamicin exposure. ORL J Otorhinolaryngol Relat Spec 1999; 61: 63–70.
- Lautermann J, McLaren J, Schacht J. Glutathione protection against ototoxicity depends on nutritional status. Hear Res 1995; 86: 15–24.
- Song BB, Anderson DJ, Schacht J. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity. Free Radie Biol Med 1998; 25: 189 95.
- Conlon BJ, Aran JM, Erre JP, Smith DW. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant a-lipoic acid. Hear Res 1999; 128: 40–4.
- Ishikawa K, Matsuzaki Z, Yokomizo M, Terada N, Miyazaki S, Togawa K. Effect of unilateral section of cervical afferent nerve upon optokinetic response and vestibular nystagmus induced by sinusoidal rotation in guinea pigs. Acta Otolaryngol Suppl (Stockh) 1998; 537: 6–10.
- Attanasio G, Spongr VP, Henderson D. Localization of F-actin and fodrin along the organ of Corti in the chinchilla. Hear Res 1994; 81: 199–207.
- Saito T, Manabe Y, Honda N, Yamada T, Yamamoto T, Saito H. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs. Scanning Microsc 1995; 9: 271–81.
- White LO, Lovering A, Reeves DS. Variations in gentamicin Cl, Cl a, C2, and C2a content of some preparations of gentamicin sulphate used clinically as determined by high-performance liquid chromatogra�phy. Ther Drug Monit 1983; 5: 123 6.
- Isoherranen N, Soback S. Determination of gentamicins CI, CI a, and C2 in plasma and urine by HPLC. Clin Chem 2000; 46: 837–42.
- Fujiwara Y. Relationships between ototoxicities and chemical structures of ototoxic drug. Nippon Jibiinkoka Gakkai Kaiho 1993; 96: 1482–9.
- Harada Y, Musso E, Mira E. Action of streptomycin, dihydrostreptomycin, neomycin and kanamycin on the ampullar receptors of the frogs. Acta Otolaryngol (Stockh) 1967; 64: 327–37.
- Molitoris BA. Cell biology of aminoglycoside nephro�toxicity: newer aspects. Curr Opin Nephrol Hypertens 1997; 6: 384–8.